[Form 4] AMGEN INC Insider Trading Activity

Amgen Inc. senior vice president Derek Miller reported a routine tax-withholding transaction in company stock.

Rhea-AI Filing Summary

Amgen Inc. senior vice president Derek Miller reported a routine tax-withholding transaction in company stock. On March 16, 2026, 1,616 shares of Amgen common stock were disposed of at $366.21 per share to satisfy tax obligations related to equity compensation. Following this withholding, Miller directly holds 12,173 shares, which include 197 dividend equivalents tied to unvested restricted stock units that will pay out in shares as they vest.

Insider Trade Summary

Exercise Price or Tax Liability: 1,616 shares

Exercise Price or Tax Liability 1 txn

Insider Miller Derek

Role SVP, Human Resources

Type	Security	Shares	Price	Value
Exercise Price or Tax Liability	Common Stock	1,616	$366.21	$592K

Holdings After Transaction: Common Stock — 12,173 shares (Direct)

Footnotes (1)

1. F1. These shares include 197 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. Second Amended and Restated 2009 Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited to the reporting person's unvested Restricted Stock Units and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Derek Miller report for Amgen (AMGN)?

Derek Miller reported a tax-withholding disposition of 1,616 Amgen shares at $366.21 per share. The shares were surrendered to cover tax liabilities from equity compensation, not sold on the open market, and reflect a routine administrative transaction.

How many Amgen (AMGN) shares does Derek Miller hold after this Form 4?

After the tax-withholding transaction, Derek Miller directly holds 12,173 Amgen common shares. This total includes 197 dividend equivalents credited to his unvested restricted stock units, which will convert into shares as those awards vest under the company’s equity plan.

Was Derek Miller’s Amgen (AMGN) Form 4 an open-market stock sale?

No, the Form 4 shows a tax-withholding disposition, not an open-market sale. The 1,616 shares were delivered to cover tax liabilities associated with equity awards, a common administrative mechanism that does not involve selling shares to public market buyers.

What are the dividend equivalents mentioned in Derek Miller’s Amgen (AMGN) filing?

The filing notes 197 dividend equivalents granted under Amgen’s equity incentive plan. These are credits tied to unvested restricted stock units that track dividends and will be paid out in Amgen common shares, plus cash for any fractional amounts, when the units vest.

What does transaction code "F" mean in the Amgen (AMGN) Form 4?

Transaction code “F” indicates shares were used to pay an exercise price or tax liability. In this case, 1,616 Amgen shares were withheld to satisfy tax obligations from equity compensation, classifying the move as a tax-withholding disposition rather than a discretionary stock sale.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 03/18/2026 - 08:37 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Miller Derek

(Last) (First) (Middle)

ONE AMGEN CENTER DRIVE

(Street)

THOUSAND OAKS CALIFORNIA 91320

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
AMGEN INC [ AMGN ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	SVP, Human Resources

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
03/16/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	03/16/2026		F		1,616	D	$366.21	12,173(1)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. These shares include 197 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. Second Amended and Restated 2009 Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited to the reporting person's unvested Restricted Stock Units and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount.

	/s/ Derek Miller	03/17/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)